MedPath

Effect of high-dose DPP-4 inhibitor or single-dose rapid-acting insulin on glycemic control in type 2 diabetic patients treated with regular-dose DPP-4 inhibitor and long-acting insuli

Not Applicable
Conditions
type 2 diabetes mellitus
Registration Number
JPRN-UMIN000010211
Lead Sponsor
Shiraiwa Medical Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

- severe hepatic, renal, and/or cardiac disease - hypersensitivity to the drug using in the study - pregnant or breastfeeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glycemic control assessed with self-monitoring of blood glucose
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath